Upper urinary tract urothelial carcinoma with loco‐regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration

Study Type – Therapy (multi‐insititutional cohort)

[1]  F. Montorsi,et al.  Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. , 2010, The Journal of urology.

[2]  R. Millikan,et al.  Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinoma , 2010, Cancer.

[3]  K. Bensalah,et al.  Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. , 2009, European urology.

[4]  K. Bensalah,et al.  Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. , 2009, The Journal of urology.

[5]  Y. Lotan,et al.  Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration , 2009, Cancer.

[6]  P. O’Donnell,et al.  The Role of Chemotherapy in Upper Tract Urothelial Carcinoma , 2009, Advances in urology.

[7]  V. Kouloulias,et al.  Comprehensive Management of Upper Tract Urothelial Carcinoma , 2008, Advances in urology.

[8]  U. Capitanio,et al.  Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. , 2008, European urology.

[9]  K. Pummer,et al.  Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. , 2008, European urology.

[10]  M. Brausi,et al.  Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. , 2007, European urology.

[11]  J. Raman,et al.  Management of patients with upper urinary tract transitional cell carcinoma , 2007, Nature Clinical Practice Urology.

[12]  J. Chin,et al.  Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. , 2004, The Journal of urology.

[13]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.

[14]  M. Droller.  Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. , 2002, The Journal of urology.

[15]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[16]  C. Dinney,et al.  Complications of radical cystectomy: impact of the timing of perioperative chemotherapy. , 1996, Urology.

[17]  I. Tannock,et al.  M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience. , 1989, The Journal of urology.

[18]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[19]  F. Mostofi,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.